Significantly more weight loss seen with tirzepatide versus semaglutide
Jul 08, 2024
Patients with overweight or obesity receiving tirzepatide were significantly more likely to achieve ≥5, ≥10 and ≥15% weight loss.
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
Coverage for Medicare’s e-visits still available, though few patients use service
By
Kristen Fischer
Apr 16, 2024
E-visits, which drew expanded coverage during the pandemic still are available but not used often, a new study shows.
ACC: Semaglutide beneficial in obesity-related heart failure, type 2 diabetes
Apr 09, 2024
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.
Nerve decompression may ease painful diabetic peripheral neuropathy
Mar 28, 2024
Nerve decompression was associated with reduced pain, but equal improvement was seen in decompressed and sham legs.
Eli Lilly reports temporary shortage of Humalog and Insulin Lispro Injection
Mar 25, 2024
Products are expected to be out of stock at wholesalers and pharmacies through the beginning of April.
Fresh, delivered produce tied to improvements in CVD risk factors
Mar 22, 2024
Significant improvements were seen for produce consumption, physical activity, non-high-density lipoprotein cholesterol and HbA1c.
Disease knowledge limited among individuals with type 2 diabetes
Mar 13, 2024
The item with lowest percentage of correct answers (4.4%) was related to identification of signs of ketoacidosis.
In trial, researchers test EHR alerts to lower harmful screenings, overtreatment in seniors
By
Kristen Fischer
Feb 15, 2024
Researchers devised a new way to ensure that older adults aren’t being overtreated or tested needlessly via unnecessary screenings.
Diabetic retinopathy tied to lower vision-related quality of life
Feb 06, 2024
Greater declines in quality of life were seen for higher-severity diabetic retinopathy.